Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): Novel gene therapeutic for metastatic melanoma

Toxicology and Applied Pharmacology

Volumn 224, Issue 3, 2007, Pages 300-307

  Fisher, Paul B ^a   Sarkar, Devanand ^a   Lebedeva, Irina V ^a   Emdad, Luni ^a   Gupta, Pankaj ^a   Sauane, Moira ^a   Su, Zao zhong ^a   Grant, Steven ^b   Dent, Paul ^c   Curiel, David T ^d   Senzer, Neil ^e   Nemunaitis, John ^e  

^a NewYork Presbyterian Hospital   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e Mary Crowley Medical Research Center   (United States)

Author keywords

Apoptosis; mda 7 IL 24; Metastatic melanoma; Phase I clinical trial

Indexed keywords

ADENOVIRUS VECTOR; INGN 241; INTERLEUKIN 24; UNCLASSIFIED DRUG;

ADVANCED CANCER; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER GENE THERAPY; CLINICAL TRIAL; DIFFERENTIATION INDUCTION SUBTRACTION HYBRIDIZATION; HUMAN; HYBRIDIZATION; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MELANOMA CELL; METASTASIS; MOLECULAR CLONING; NONHUMAN; NUDE MOUSE; REVIEW; SIGNAL TRANSDUCTION; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR XENOGRAFT; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; APOPTOSIS; CLINICAL TRIALS, PHASE I AS TOPIC; GENE THERAPY; HUMANS; INTERLEUKINS; MELANOMA; MODELS, BIOLOGICAL; NEOPLASM METASTASIS;

ADENOVIRIDAE; ANIMALIA; MUS MUSCULUS;

EID: 34248146982     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2006.11.021     Document Type: Review

References (47)

1. Allen M., Pratscher B., Roka F., Krepler C., Wacheck V., Schofer C., Pehamberger H., Muller M., and Lucas T. Loss of novel mda-7 splice variant (mda-7s) expression is associated with metastatic melanoma. J. Invest. Dermatol. 123 (2004) 583-588
2. Atallah E., and Flaherty L. Treatment of metastatic malignant melanoma. Curr. Treatm. Opt. Oncol. 6 (2005) 185-193
3. Atkins M.B. Cytokine-based therapy and biochemotherapy for advanced melanoma. Clin. Cancer Res. 12 (2006) 2343s-2358s
4. Boukerche H., Su Z.-z., Emdad L., Baril P., Balme B., Thomas L., Randolph A., Valerie K., Sarkar D., and Fisher P.B. Mda-9/Syntenin: a positive regulator of melanoma metastasis. Cancer Res. 65 (2005) 10901-10911
5. Clark W.H. Tumor progression and the nature of cancer. Br. J. Cancer 64 (1991) 631-644
6. Caudell E.G., Mumm J.B., Poindexter N., Ekmekcioglu S., Mhashilkar A.M., Yang X.H., Retter M.W., Hill P., Chada S., and Grimm E.A. The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24. J. Immunol. 168 (2002) 6041-6046
7. Chada S., Mhashilkar A.M., Ramesh R., Mumm J.B., Sutton R.B., Bocangel D., Zheng M., Grimm E.A., and Ekmekcioglu S. Bystander activity of Ad-mda7: human MDA-7 protein receptor-dependent but STAT3-independent mechanism. Mol. Ther. 10 (2004) 1085-1095
8. Cunningham C.C., Chada S., Merritt J.A., Tong A., Senzer N., Zhang Y., Mhashilkar A., Parker K., Vukelja S., Richards D., Hood J., Coffee K., and Nemunaitis J. Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study. Mol. Ther. 11 (2005) 149-159
9. Eggermont A.M.M. Randomized trials in melanoma: an update. Surg. Oncol. Clin. N. Am. 15 (2006) 439-451
10. Ekmekcioglu S., Ellerhorst J., Mhashilkar A.M., Sahin A.A., Read C.M., Prieto V.G., Chada S., and Grimm E.A. Down-regulated melanoma differentiation associated gene (mda-7) expression in human melanomas. Int. J. Cancer 94 (2001) 54-59
11. Ellerhorst J.A., Prieto V.G., Ekmekcioglu S., Broemeling L., Yekell S., Chada S., and Grimm E.A. Loss of MDA-7 expression with progression of melanoma. J. Clin. Oncol. 20 (2002) 1069-1074
12. Fisher P.B. Is mda-7/IL-24 a 'magic bullet' for cancer?. Cancer Res. 65 (2005) 10128-10138
13. Fisher P.B., Prignoli D.R., Hermo Jr. H., Weinstein I.B., and Pestka S. Effects of combined treatment with interferon and mezerein on melanogenesis and growth in human melanoma cells. J. Interf. Res. 5 (1985) 11-22
14. Fisher P.B., Gopalkrishnan R.V., Chada S., Ramesh R., Grimm E.A., Rosenfeld M.R., Curiel D.T., and Dent P. mda-7/IL-24, A novel cancer selective apoptosis inducing cytokine gene: from the laboratory into the clinic. Cancer Biol. Ther. 2 (2003) S23-S37
15. Gupta P., Su Z.-z., Lebedeva I.V., Sarkar D., Sauane M., Emdad L., Bachelor M.A., Grant S., Curiel D.T., Dent P., and Fisher P.B. mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine. Pharmacol. Ther. 111 (2006) 596-628
16. Hauschild A., Egberts F., Russo P., and Kahler K.C. Individualized therapy of disseminated cancer using malignant melanoma as a model. Cancer Metastasis Rev. 25 (2006) 253-256
17. Herlyn M. Molecular targets in melanoma: strategies and challenges for diagnosis and therapy. Int. J. Cancer 118 (2006) 523-526
18. Huang F., Adelman J., Jiang H., Goldstein N.I., and Fisher P.B. Differentiation induction subtraction hybridization (DISH): an approach for cloning genes differentially expressed during growth arrest and terminal differentiation in human melanoma cells. Gene 236 (1999) 125-131
19. Huang E.Y., Madireddi M.T., Gopalkrishnan R.V., Leszczyniecka M., Su Z.-z., Lebedeva I.V., Kang D.-c., Jiang H., Lin J.J., Alexandre D., Chen Y., Vozhilla N., Mei M.X., Christiansen K.R., Sivo F., Goldstein N.I., Mhashilkar A.B., Chada S., Huberman E., Pestka S., and Fisher P.B. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties. Oncogene 20 (2001) 7051-7063
20. Jiang H., and Fisher P.B. Use of a sensitive and efficient subtraction hybridization protocol for the identification of genes differentially regulated during the induction of differentiation in human melanoma cells. Mol. Cell. Differ. 1 (1993) 285-299
21. Jiang H., Su Z.-Z., Boyd J., and Fisher P.B. Gene expression changes associated with reversible growth suppression and the induction of terminal differentiation in human melanoma cells. Mol. Cell. Differ. 1 (1993) 41-66
22. Jiang H., Lin J., and Fisher P.B. A molecular definition of terminal cell differentiation in human melanoma cells. Mol. Cell. Differ. 2 (1994) 221-239
23. Jiang H., Lin J.J., Su Z.-z., Goldstein N.I., and Fisher P.B. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 11 (1995) 2477-2486
24. Jiang H., Lin J., Su Z.-Z., Kerbel R.S., Herlyn M., Weissman R.B., Welch D., and Fisher P.B. The melanoma differentiation associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. Oncogene 10 (1995) 1855-1864
25. Jiang H., Su Z.-z., Lin J.J., Goldstein N.I., Young C.S.H., and Fisher P.B. The melanoma differentiation associated gene mda-7 suppresses cancer cell growth. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 9160-9165
26. Jiang H., Kang D.-c., Alexandre D., and Fisher P.B. RaSH, a rapid subtraction hybridization approach for identifying and cloning differentially expressed genes. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 12684-12689
27. Kang D.-c., La France R., Su Z.-z., and Fisher P.B. Reciprocal subtraction differential RNA display: an efficient and rapid procedure for isolating differentially expressed gene sequences. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 13788-13793
28. Kang D.-c., Gopalkrishnan R.V., Wu Q., Jankowsky E., Pyle A.M., and Fisher P.B. mda-5, an interferon-inducible putative RNA helicase with dsRNA-dependent ATPase activity and melanoma growth suppressive properties. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 637-642
29. Kirkwood J.M., Moschos S., and Wang W. Strategies for the development of more effective adjuvant therapy of melanoma: current and future explorations of antibodies, cytokines, vaccines, and combinations. Clin. Cancer Res. 12 (2006) 2331s-2336s
30. Lebedeva I.V., Su Z.-z., Chang Y., Kitada S., Reed J.C., and Fisher P.B. The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells. Oncogene 21 (2002) 708-718
31. Lebedeva I.V., Sauane M., Gopalkrishnan R.V., Sarkar D., Su Z.-z., Gupta P., Nemunaitis J., Cunningham C., Yacoub A., Dent P., and Fisher P.B. mda-7/IL-24: exploiting cancer's Achilles' heel. Mol. Ther. 11 (2005) 4-18
32. Lebedeva I.V., Sarkar D., Su Z.-z., Gopalkrishnan R.V., Athar M., Randolph A., Valerie K., Dent P., and Fisher P.B. Molecular target-based therapy of pancreatic cancer. Cancer Res. 66 (2006) 2403-2413
33. Leszczyniecka M., Roberts T., Dent P., Grant S., and Fisher P.B. Differentiation therapy of cancer: basic science and clinical applications. Pharmacol. Ther. 90 (2001) 105-156
34. Lin L., Su Z.-z., Lebedeva I.V., Gupta P., Boukerche H., Rai T., Barber G.N., Dent P., Sarkar D., and Fisher P.B. Activation of Ras/Raf protects cells from melanoma differentiation associated gene-5-induced apoptosis. Cell Death Differ. 13 (2006) 1982-1993
35. Miyahara R., Banerjee S., Kawano K., Efferson C., Tsuda N., Miyahara Y., Ioannides C.G., and Chada S. Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model. Cancer Gene Ther. 13 (2006) 753-761
36. Sainz-Perez A., Gary-Gouy H., Portier A., Davi F., Merle-Beral H., Galanaud P., and Dalloul A. High mda-7 expression promotes malignant cell survival and p38 MAP kinase activation in chronic lymphocytic leukemia. Leukemia 20 (2006) 498-504
37. Sarkar D., Su Z.-z., Lebedeva I.V., Sauane M., Gopalkrishnan R.V., Valerie K., Dent P., and Fisher P.B. mda-7 (IL-24) mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 10054-10059
38. Sarkar D., Boukerche H., Su Z.-z., and Fisher P.B. mda-9/syntenin: recent insights into a novel cell signaling and metastasis-associated gene. Pharmacol. Ther. 104 (2004) 101-115
39. Sarkar D., Su Z.Z., Vozhilla N., Park E.S., Gupta P., and Fisher P.B. Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 14034-14039
40. Sarkar D., Su Z.-z., and Fisher P.B. Unique conditionally replication competent bipartite adenoviruses-cancer terminator viruses (CTV): efficacious reagents for cancer gene therapy. Cell Cycle 5 (2006) 1531-1536
41. Sauane M., Gopalkrishnan R.V., Sarkar D., Su Z.-z., Lebedeva I.V., Dent P., Pestka S., and Fisher P.B. MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine. Cytokine Growth Factor Rev. 14 (2003) 35-51
42. Sauane M., Gopalkrishnan R.V., Choo H.T., Gupta P., Lebedeva I.V., Yacoub A., Dent P., and Fisher P.B. Mechanistic aspects of mda-7/IL-24 cancer cell selectivity analysed via a bacterial fusion protein. Oncogene 23 (2004) 7679-7690
43. Sauane M., Gupta P., Lebedeva I.V., Su Z.-z., Sarkar D., Randolph A., Valerie K., Gopalkrishnan R.V., and Fisher P.B. N-glycolsylation of MDA-7/IL-24 is dispensable for tumor cell-specific apoptosis and "bystander" anti-tumor activity. Cancer Res. 66 (2006) 11869-11877
44. Su Z.-z., Lebedeva I.V., Gopalkrishnan R.V., Goldstein N.I., Stein C.A., Reed J.C., Dent P., and Fisher P.B. A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 10332-10337
45. Su Z.-z., Emdad L., Sauane M., Lebedeva I.V., Sarkar D., Gupta P., James C.D., Randolph A., Valerie K., Walter M.R., Dent P., and Fisher P.B. Unique aspects of mda-7/IL-24 antitumor bystander activity: establishing a role for secretion of MDA-7/IL-24 protein by normal cells. Oncogene 24 (2005) 7552-7566
46. Tong A.W., Nemunaitis J., Su D., Zhang Y., Cunningham C., Senzer N., Netto G., Rich D., Mhashilkar A., Parker K., Coffee K., Ramesh R., Ekmekcioglu S., Grimm E.A., van Wart Hood J., Merritt J., and Chada S. Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients. Mol. Ther. 11 (2005) 160-172
47. Zhao L., Gu J., Dong A., Zhang Y., Zhong L., He L., Wang Y., Zhang J., Zhang Z., Huiwang J., Qian Q., Qian C., and Liu X. Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer. Hum. Gene Ther. 16 (2005) 845-858